VKTX
Viking Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$35.63
+0.16 ▲ +0.45%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$35.39
-0.24 ▼ -0.67%
| Index | - | P/E | - | EPS (ttm) | -3.18 | Insider Own | 2.96% | Shs Outstand | 0.11B | Perf Week | 8.04% |
| Market Cap | 4.12B | Forward P/E | - | EPS next Y | -8.39% | Insider Trans | -12.12% | Shs Float | 0.11B | Perf Month | 24.8% |
| Enterprise Value | 3.41B | PEG | - | EPS next Q | -1 | Inst Own | 62.82% | Short Float | 21.69% | Perf Quarter | -5.06% |
| Income | -0.36B | P/S | - | EPS this Y | -32.76% | Inst Trans | -1.12% | Short Ratio | 8.23 | Perf Half Y | 38.42% |
| Sales | 0.00B | P/B | 6.4 | EPS next 5Y | -9.28% | ROA | -44.29% | Short Interest | 24.32M | Perf YTD | 1.28% |
| Book/sh | 5.57 | P/C | 5.83 | EPS past 3/5Y | -52.71% -42.46% | ROE | -47.34% | 52W High | -17.43% ($43.15) | Perf Year | 19.85% |
| Cash/sh | 6.11 | P/FCF | - | Sales past 3/5Y | - | ROIC | -56.28% | 52W Low | 88.32% ($18.92) | Perf 3Y | 238.37% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -215.49% | Gross Margin | - | Volatility(W/M) | 5.26% 5.92% | Perf 5Y | 427.85% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.9 | Perf 10Y | 1815.59% |
| Dividend Ex-Date | - | Quick Ratio | 9.33 | EPS Q/Q | -334.74% | Profit Margin | - | RSI (14) | 62.37 | Recom | 1.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.33 | Sales Q/Q | - | SMA20 | 8.48% ($32.84) | Beta | 0.79 | Target Price | $93.59 |
| Payout | - | Debt/Eq | 0 | Earnings | 2000000 | SMA50 | 11.53% ($31.95) | Rel Volume | 0.94 | Prev Close | $35.47 |
| Employees | 53 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -55.02% - | SMA200 | 12.01% ($31.81) | Avg Volume(3M) | 2.96M | Price | $35.63 |
| IPO | 2015/4/29 | Option/Short | Yes/Yes | Trades | 25655 | Volume | 2,783,067 | Change | 0.45% |
뉴스 로딩 중...